Tag: Anticoagulants
Racial Disparities Seen in Use of Oral Anticoagulants for A-Fib
When treated for atrial fibrillation, quality of anticoagulant use lower in blacks, Hispanics
Net Benefit of Anticoagulants for A-Fib Varies With Stroke Rate
Benefit of warfarin anticoagulation varies with varying published stroke rates
Apixaban Is Safest Direct Oral Anticoagulant Versus Warfarin
Reduced risks of major, intracranial, and gastrointestinal bleeding compared with warfarin
Reduced-Dose Anticoagulants Feasible for Extended VTE Tx
May be as effective as full-dose direct oral anticoagulants for extended-duration treatment
Extended INR Test Intervals Safe for Warfarin-Treated Patients
Similar number of out-of-range next INR values for patients with, without extended testing interval
Clopidogrel + Aspirin Cuts Ischemic Events in Stroke, TIA
However, combination is associated with increased risk of major hemorrhage within 90 days
Anticoagulants in Seniors With A-Fib, CKD Ups Stroke, ICH Risk
Anticoagulants linked to increased risk of ischemic stroke and hemorrhage, but lower all-cause mortality
Anticoagulation Guidance Issued for Cardiopulmonary Bypass
Recommendations for heparin dosing and monitoring, contraindications and alternatives, reversal
Ocular Safety Profile of Novel Oral Antithrombotics Explored
Prasugrel has no increased ocular risk versus clopidogrel; dabigatran, rivaroxaban may reduce risk
Pharmacomechanical Thrombolysis No Benefit in DVT
Addition of pharmacomechanical catheter-directed thrombolysis resulted in higher risk of bleeding
